+444.8%
NVDA vs GH
+45.9%
+398.8%
-66.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | GH | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.0% | -2.0% | 0.0% | -1.5% |
| 7D | -12.7% | +0.6% | -13.3% | -12.9% |
| 30D | -26.4% | -6.9% | -19.5% | -25.1% |
| 3M | -27.6% | -4.9% | -22.7% | -27.1% |
| 6M | -27.7% | +54.1% | -81.8% | -36.2% |
| YTD | -12.5% | +48.5% | -61.0% | -22.9% |
| 1Y | -12.6% | +61.2% | -73.8% | -24.8% |
| 3Y | +235.9% | +570.3% | -334.4% | +75.3% |
| All | +444.8% | +45.9% | +398.8% | +315.2% |
Cumulative growth
Daily Returns
Daily percentage return beside GH.
Daily Out/Under-Performance
Portfolio return minus GH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded GH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling